SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 130 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $393,413 | -46.5% | 1,098,000 | 0.0% | 0.02% | -60.5% |
| Q1 2024 | $735,880 | -1.3% | 1,098,000 | -20.0% | 0.04% | +52.0% |
| Q4 2023 | $745,408 | -9.4% | 1,372,000 | 0.0% | 0.02% | -13.8% |
| Q3 2023 | $822,926 | -50.2% | 1,372,000 | +7.9% | 0.03% | -61.3% |
| Q2 2023 | $1,653,600 | -12.4% | 1,272,000 | +18.7% | 0.08% | -29.9% |
| Q1 2023 | $1,886,720 | -43.9% | 1,072,000 | 0.0% | 0.11% | -53.9% |
| Q4 2022 | $3,366,080 | +29.6% | 1,072,000 | +102.3% | 0.23% | -8.3% |
| Q3 2022 | $2,597,000 | +18.4% | 530,000 | 0.0% | 0.25% | +10.0% |
| Q2 2022 | $2,194,000 | +11.1% | 530,000 | +55.9% | 0.23% | -9.4% |
| Q1 2022 | $1,975,000 | +7.5% | 340,000 | +38.8% | 0.25% | +4.5% |
| Q4 2021 | $1,838,000 | – | 245,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
| Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
| McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
| Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
| Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
| EMC Capital Management | 72,061 | $903,000 | 0.64% |
| WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
| Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
| Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
| Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |